In vivo and in vitro disposition profile of tezosentan, an intravenous dual endothelin receptor antagonist, in humans

The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo

British Journal of Pharmacology ◽

10.1038/sj.bjp.0705601 ◽

2004 ◽

Vol 141 (2) ◽

pp. 215-222 ◽

Cited By ~ 7

Author(s):

Thiemo Pfab ◽

Gisela Stoltenburg-Didinger ◽

Christoph Trautner ◽

Michael Godes ◽

Christian Bauer ◽

...

Keyword(s):

Receptor Antagonist ◽

Endothelin Receptor ◽

Endothelin System ◽

Morris Hepatoma

Bosentan, a new endothelin receptor antagonist: prediction of the systemic plasma clearance in man from combined in vivo and in vitro data

Xenobiotica ◽

10.3109/00498259509061925 ◽

1995 ◽

Vol 25 (12) ◽

pp. 1381-1390 ◽

Cited By ~ 36

Author(s):

G. Ubeaud ◽

C. Schmitt ◽

D. Jaeck ◽

T. Lave ◽

Ph. Coassolo

Keyword(s):

Receptor Antagonist ◽

Plasma Clearance ◽

Endothelin Receptor ◽

Vitro Data ◽

In Vitro Data

In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide

Clinical Pharmacology & Therapeutics ◽

10.1067/mcp.2002.122473 ◽

2002 ◽

Vol 71 (4) ◽

pp. 253-262 ◽

Cited By ~ 41

Author(s):

P VANGIERSBERGEN ◽

A TREIBER ◽

M CLOZEL ◽

F BODIN ◽

J DINGEMANSE

Keyword(s):

Receptor Antagonist ◽

Pharmacokinetic Interaction ◽

In Vitro Studies ◽

Cpu0507, An Endothelin Receptor Antagonist, Improves Rat Hypoxic Pulmonary Artery Hypertension And Constriction In Vivo And In Vitro

Clinical and Experimental Pharmacology and Physiology ◽

10.1111/j.1440-1681.2006.04488.x ◽

2006 ◽

Vol 33 (11) ◽

pp. 1066-1072 ◽

Cited By ~ 8

Author(s):

Sheng-hua Yuan ◽

De-zai Dai ◽

Li Guan ◽

Yin Dai ◽

Min Ji

Keyword(s):

Pulmonary Artery ◽

Receptor Antagonist ◽

Pulmonary Artery Hypertension ◽

In vitro and in vivo pharmacokinetic characteristics of clazosentan, an intravenous endothelin receptor antagonist, in humans

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp47169 ◽

2009 ◽

Vol 47 (03) ◽

pp. 169-177 ◽

Cited By ~ 5

Author(s):

P.L.M. van Giersbergen ◽

A. Treiber ◽

J. Dingemanse

Keyword(s):

Receptor Antagonist ◽

Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670

British Journal of Pharmacology ◽

10.1111/j.1476-5381.1995.tb13351.x ◽

1995 ◽

Vol 114 (7) ◽

pp. 1327-1328 ◽

Cited By ~ 3

Author(s):

Timothy D. Warner ◽

Dean Willis ◽

Adrian R. Moore ◽

John R. Vane ◽

Peter Klemm

Keyword(s):

Receptor Antagonist ◽

Endothelin Receptor ◽

Coronary Vasoconstriction ◽

In Vivo Treatment

In vivo subcellular elemental dynamics in liver graft: With special reference to effect of non-selective endothelin receptor antagonist, TAK-044, on the graft injury

Hepatology Research ◽

10.1016/s1386-6346(99)00099-6 ◽

2000 ◽

Vol 18 (3) ◽

pp. 171-183

Author(s):

Y Takaya

Keyword(s):

Special Reference ◽

Receptor Antagonist ◽

Liver Graft ◽

Application of Serial In Vivo Magnetic Resonance Imaging to Evaluate the Efficacy of Endothelin Receptor Antagonist SB 217242 in the Rat Carotid Artery Model of Neointima Formation

Circulation ◽

10.1161/01.cir.97.22.2252 ◽

1998 ◽

Vol 97 (22) ◽

pp. 2252-2258 ◽

Cited By ~ 5

Author(s):

Sudeep Chandra ◽

Lynne V. Clark ◽

Robert W. Coatney ◽

Le Phan ◽

Susanta K. Sarkar ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Magnetic Resonance ◽

Carotid Artery ◽

Receptor Antagonist ◽

Neointima Formation ◽

Endothelin Receptor ◽

Resonance Imaging

Pharmacological Profile in vitro of A New Endothelin Receptor Antagonist, TAK-044.

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)50309-2 ◽

1994 ◽

Vol 64 ◽

pp. 167

Author(s):

Yumiko Awane ◽

Keiji Kusumoto ◽

Kazuki Kubo ◽

Akira Kawata ◽

Takashi Kikuchi ◽

...

Keyword(s):

Receptor Antagonist ◽

Endothelin Receptor ◽

Pharmacological Profile

In Vivo Pharmacology of Ro 46-2005, The First Synthetic Nonpeptide Endothelin Receptor Antagonist: Implications for Endothelin Physiology

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199322008-00099 ◽

1993 ◽

Vol 22 (Supplement 8) ◽

pp. S377-S379 ◽

Cited By ~ 34

Author(s):

Martine Clozel ◽

Volker Breu ◽

Gillian A. Gray ◽

Bernd-Michael Löffler

Keyword(s):

Receptor Antagonist ◽